Home Tags Posts tagged with "Paul Marquardt"

Tag: Paul Marquardt

Firms act on Hengrui-GSK USD12.5bn drug development deal

Jiangsu Hengrui and GSK reached a USD12.5bn deal, with Cooley, Davis Polk and Han Kun advising

Trio acts on Nippon Paint’s USD2.3bn chemical deal

Davis Polk, Gibson Dunn, and Katzke & Morgenbesser advise on Nippon Paint’s $2.3B acquisition of AOC, owned by Lone Star Funds

Davis Polk, Appleby and Latham & Watkins act on USD23bn SPAC merger

Davis Polk, Appleby and Latham & Watkins advised on a proposed special purpose acquisition company (SPAC) merger involving Vietnamese electric vehicle manufacturer VinFast at an equity value of USD23 billion

MOST READ ON LAW.ASIA

Correspondents

India Healthcare Investmentvideo

Healthcare investment in India: The PE playbook

By Ayush Jain, Bharucha & Partners
Philippine Citizenship By Marriage

Bride and prejudice: Gendered paths to Philippine citizenship

By Jewel M Culala, ACCRALAW
AI investments in Indiavideo

Rethinking due diligence for Indian AI deals

By Vandana Pai and Shreya Sreesankar, Bharucha & Partners
NCLAT shields enforcement actions

PMLA free pass dilutes insolvency moratorium

By Ambar Bhushan and Divyam Sharma, Bharucha & Partners

Follow us on LinkedIn

Follow now
This site is registered on wpml.org as a development site. Switch to a production site key to remove this banner.